Analysts’ updated eps estimates for Thursday, August 31st:

Applied Optoelectronics (NASDAQ:AAOI) had its sell rating reaffirmed by analysts at BWS Financial. The firm currently has a $25.00 target price on the stock.

Absolute Software (NASDAQ:ALSWF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Absolute Software Corporation engages in the business of providing firmware-persistent endpoint security and management solutions. It provides solutions for computer security monitoring and endpoint management industry. The company’s solutions include data protection, lifecycle management, enterprise mobility management and IT service management as well as data loss prevention. Absolute Software Corporation is headquartered in Vancouver, Canada. “

ANTA SPORTS PRODUC HKD0.10 (NASDAQ:ANPDF) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $3.00 target price on the stock. According to Zacks, “ANTA Sports Products Limited designs, develops, manufactures, trades, distributes, and markets sportswear in the People’s Republic of China. The company’s products include footwear, apparel, and accessories for professionals and the general public. ANTA Sports Products Limited is headquartered in Jinjiang City, the People’s Republic of China. “

Athersys (NASDAQ:ATHX) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The company’s lead product candidate, ATHX-105, is an oral, selective 5HT2c receptor agonist in Phase I clinical trials for the treatment of obesity. The company is also developing other orally active pharmaceutical product candidates for the treatment of metabolic and central nervous system disorders, utilizing proprietary technologies, including Random Activation of Gene Expression (RAGE). Athersys is developing MultiStem(r), its patented, adult-derived “off the shelf” stem cell product platform, for multiple disease indications, including damage caused by myocardial infarction, bone marrow transplantation/oncology support, ischemic stroke and other indications. “

Bellerophon Therapeutics (NASDAQ:BLPH) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Bellerophon Therapeutics LLC is a biotherapeutics company. It is focused on developing products for the treatment of cardiopulmonary and cardiac diseases. The company’s product pipeline consists of INOpulse and BCM which are in different clinical stage. Bellerophon Therapeutics LLC is based in Hampton, New Jersey. “

Bank of Commerce Holdings (CA) (NASDAQ:BOCH) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Bank of Commerce Holdings is a financial service holding company that owns Redding Bank of Commerce, Roseville Bank of Commerce, a division of Redding Bank of Commerce and Bank of Commerce Mortgage, an affiliate of Redding Bank of Commerce and Roseville Bank of Commerce. “

Caleres (NYSE:CAL) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $30.00 price target on the stock. According to Zacks, “Caleres, Inc. is a footwear retailer and wholesaler. The Company is involved in the operation of retail shoe stores and e-commerce Websites as well as the design, sourcing and marketing of footwear for women and men. Its operating segment consists of Famous Footwear and Brand Portfolio. The company brands include Nike, Skechers, Bearpaw, Converse, Vans, New Balance, adidas, Asics, Sperry and Sof Sole, LifeStride, Dr. Scholl’s, Fergalicious, Naturalizer and Carlos. Caleres, Inc., formerly known as Brown Shoe Company, Inc., is headquartered in St. Louis, Missouri. “

Costco Wholesale Corporation (NASDAQ:COST) had its neutral rating reiterated by analysts at Guggenheim. The firm currently has a $140.00 target price on the stock.

Cypress Semiconductor Corporation (NASDAQ:CY) had its buy rating reiterated by analysts at Craig Hallum. Craig Hallum currently has a $20.00 target price on the stock.

Golar LNG Limited (NASDAQ:GLNG) had its outperform rating reaffirmed by analysts at Cowen and Company. The firm currently has a $45.00 target price on the stock.

GlaxoSmithKline PLC (NYSE:GSK) had its buy rating reaffirmed by analysts at Argus. The firm currently has a $50.00 price target on the stock.

Otonomy (NASDAQ:OTIC) had its outperform rating reaffirmed by analysts at Cowen and Company. Cowen and Company currently has a $9.00 target price on the stock, down from their previous target price of $55.00.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.